Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Azathioprine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myasthenia Gravis 3 Skin Neoplasms 1 Carcinoma, Hepatocellular 1 Arthritis, Rheumatoid 1

Interventions

pembrolizumab 20 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 fludarabine 14 Interleukin-2 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 Vemurafenib 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 binimetinib 4 Temozolomide 4 Surgical Procedures, Operative 4 Sirolimus 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 encorafenib 3 avelumab 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡